|
PATZ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.122300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.351600E-02 |
| Normal-vs-Stage2 |
3.921600E-01 |
| Normal-vs-Stage3 |
3.328500E-02 |
| Normal-vs-Stage4 |
8.216900E-04 |
| Stage1-vs-Stage2 |
5.543400E-01 |
| Stage1-vs-Stage3 |
6.051200E-01 |
| Stage1-vs-Stage4 |
3.018300E-02 |
| Stage2-vs-Stage3 |
3.770200E-01 |
| Stage2-vs-Stage4 |
7.560200E-02 |
| Stage3-vs-Stage4 |
1.635840E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.226400E-02 |
| Normal-vs-AfricanAmerican |
3.104800E-01 |
| Normal-vs-Asian |
6.600300E-02 |
| Caucasian-vs-AfricanAmerican |
7.113200E-01 |
| Caucasian-vs-Asian |
9.619800E-01 |
| AfricanAmerican-vs-Asian |
7.946600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.126200E-01 |
| Normal-vs-Female |
8.081900E-03 |
| Male-vs-Female |
1.267020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.284700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.767600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.651900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.701600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.990610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.438800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.053800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.759200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.228200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.948400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.945600E-02 |
| Classical-VS-Follicular |
5.043800E-01 |
| Classical-VS-Other |
7.512600E-01 |
| Classical-VS-Normal |
5.060500E-02 |
| Tall-VS-Follicular |
4.621400E-01 |
| Tall-VS-Other |
8.019000E-01 |
| Tall-VS-Normal |
5.421200E-03 |
| Follicular-VS-Other |
9.846800E-01 |
| Follicular-VS-Normal |
5.246100E-02 |
| Other-VS-Normal |
3.229800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.499800E-02 |
| Normal-vs-N1 |
1.788260E-04 |
| N0-vs-N1 |
4.139900E-03 |
|
|
